GSK stock drops after 60 Minutes segment; Ritedose recalls Albuterol;

> GlaxoSmithKline was the biggest decliner among the large-cap pharma stocks Tuesday, down three percent, following the 60 Minutes segment featuring manufacturing-quality whistleblower Cheryl Eckard; it dropped 2.3 percent on Wednesday. Article

> Ritedose is recalling an Albuterol sulfate inhalation solution because some single-use vials have an incorrect concentration embossing. Notice

> The European Medicines Agency cites the quality of APIs manufactured outside the EU as an area of concern in its draft 2015 road map. Story

> McGuff Pharmaceuticals has been warned by the FDA for its lack of validation of supplier API; also noteworthy is the speed of the FDA's posting of the letter: seven days (including the holiday) from issue date. Warning Letter 19-11

>The EPA lists estrogen among its drinking water contaminant candidates and cites pharmaceuticals as the source; A UCSF study finds agricultural sources: dairy cow excretions. Article

> The UK Department of Health says it is moving flu vaccine supplies around the country to shore up the regions that are experiencing shortages. News

> India, too, is readying for shortages of vaccines following the closure of government-run production units. Article

> From the pallet front: With prompting from the National Wooden Pallet and Container Association, U.S. Senator Christopher Dodd has urged the FDA to increase surveillance of plastic pallets containing the decaBDE fire retardant, and to provide training so inspectors can identify them. Release

> API contract manufacturer Parabolic Drugs has completed the first phase of an expansion program with the commissioning of a plant comprising five manufacturing blocks in Punjab, India. Item